Etonogestrel contraceptive implant failure in a woman taking rifampin: a case report

BACKGROUND: The etonogestrel subdermal implant is the most efficacious hormonal contraceptive currently available and provides 99.7% effective contraception. However, similar to other hormonal contraception, its effectiveness is compromised with the use of cytochrome P450 inducing drugs resulting in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tufa, Tesfaye H., Fessehaye, Abraham, Abubeker, Ferid A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069719/
https://www.ncbi.nlm.nih.gov/pubmed/35509087
http://dx.doi.org/10.1186/s40834-022-00172-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069719/
https://www.ncbi.nlm.nih.gov/pubmed/35509087
http://dx.doi.org/10.1186/s40834-022-00172-1

Ejemplares similares